|Bid||32.03 x 1800|
|Ask||32.57 x 1000|
|Day's Range||32.50 - 33.13|
|52 Week Range||32.50 - 75.63|
|Beta (5Y Monthly)||1.75|
|PE Ratio (TTM)||14.30|
|Earnings Date||Apr. 21, 2020 - Apr. 26, 2020|
|Forward Dividend & Yield||1.00 (3.05%)|
|Ex-Dividend Date||Jan. 22, 2020|
|1y Target Est||41.81|
Potential Core Laboratories N.V. (NYSE:CLB) shareholders may wish to note that the COO, President & Supervisory...
Core Laboratories (CLB) delivered earnings and revenue surprises of 0.00% and 1.08%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Supermajor ExxonMobil (XOM) issued an update on its upcoming fourth-quarter earnings. Meanwhile, Core Labs (CLB) slashed its dividend by 55% and lowered fourth-quarter guidance.
Core Labs (CLB) initiates a preliminary view for the first quarter of 2020 wherein it expects its quarterly revenues within $159-$164 million and earnings per share in the 39-41 cents range.
(Bloomberg Opinion) -- “When does it end?” is a perfectly reasonable question for New Year’s Eve. And in the case of anyone still holding onto oilfield services stocks, it is more than rhetorical.Core Laboratories NV, which offers services to enhance output from oilfields, dropped the ball early on Thursday evening, or New Year’s Eve Eve if you will. It cut guidance for the quarter just about to end, issued underwhelming guidance for the quarter about to begin and, to cap it off, slashed its dividend by more than half. The latter was declared “sacrosanct” by management only two months ago — which, in hindsight, is one of those overwrought words that should set alarm bells ringing. Throw in Tuesday’s pre-drinking trading volumes, and the stock looks set to see out 2019 with a bang (not the good kind).The ostensible reason for the sudden about-face is sluggish activity in international markets, which were hoped to offset the drag from the slowdown in U.S. fracking. The underlying reason is one that blends the oil business with New Year’s Eve seamlessly: the triumph of hope over experience.It is telling that Core Labs last raised its dividend in the second quarter of 2016, just after oil prices had bottomed out below $30 a barrel. At the time, the company anticipated a “V-shaped” recovery in commodity markets. But the seams were splitting. Shareholder equity had already dipped further into deficit in the first quarter of that year as dividends outpaced earnings. And a month after raising the dividend, Core Labs sold another $175 million of stock to help pay down its revolver.In short, the company was paying a pre-crash dividend on post-crash cash flows in the hope that the inevitable swing up in oil prices would make it all balance out. Core Labs was certainly not alone in this thinking. But the oil market’s “V” turned out to be more a series of w’s.Consequently, net debt to Ebitda has almost doubled since the middle of 2018, hitting 2.8 times at the end of September. By then, analysts were speculating about whether Core Labs would have to cut its dividend, just as they were back in early 2016. Yet analysts also remained bullish, with 16 recommending holding or buying the stock and just one advocating selling before Monday evening’s announcement.In some respects, affinity for Core Labs is understandable. Capital intensity is low, and the company generates free cash flow consistently. Executive pay is also tied mostly to financial metrics. And, of course, Core Labs has striven to maintain the dividend.The problem is that, in key respects, these perceived strengths rest on an anachronism. Compensation, while tied to financial performance, also remains tied overwhelmingly to relative rather than absolute performance — which doesn’t do much for shareholders in an energy sector this troubled. Meanwhile, sticking with a dividend is laudable only if it isn’t hollowing out your balance sheet and, as the risk premium rises, the stock price it ostensibly supports.Core Labs has finally done the right thing but will inevitably pay a heavy price, at least in the short term. Beware oilfield services stocks as a whole, however, which are up almost a fifth this month on the back of a 10% rally in oil prices. Core Labs’ capitulation suggests the sector is about to undergo another round of warnings and cuts to guidance and forecasts as expectations of recovery get pushed out again.One silver lining (it is New Year’s Eve, after all) is that the oilfield services sector’s continuing woes indicate that recently-discovered discipline on the part of exploration and production companies may be sticking. This, in turn, would start to restore resilience to the contractors’ customer base and, by reining in U.S. supply, offer support to oil prices.If that sounds like a lot of ifs and maybes strung together, that’s because it is. Core Labs’ cut closes out a decade in which the oil business in general stuck with a growth model relying implicitly on higher oil prices filling gaps in cash flow — while that same dash for growth undermined those oil prices. As most of us know from bitter experience, a truly happy new year begins with a little restraint beforehand.To contact the author of this story: Liam Denning at email@example.comTo contact the editor responsible for this story: Mark Gongloff at firstname.lastname@example.orgThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Liam Denning is a Bloomberg Opinion columnist covering energy, mining and commodities. He previously was editor of the Wall Street Journal's Heard on the Street column and wrote for the Financial Times' Lex column. He was also an investment banker.For more articles like this, please visit us at bloomberg.com/opinion©2020 Bloomberg L.P.
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
Is Core Laboratories N.V. (NYSE:CLB) a good dividend stock? How can we tell? Dividend paying companies with growing...
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Generally speaking long term investing is the way to go. But unfortunately, some companies simply don't succeed...
Better crude oil market fundamentals are likely to scale up international activities, thereby boosting the prospects of Core Laboratories' (CLB) Reservoir Description unit.
Significant exposure to profitable international markets have helped Schlumberger (SLB) and Halliburton (HAL) combat weak North American operations in third-quarter 2019.
Although weak oil pricing and conservative capital spending by US explorers might have acted as headwinds in Q3, rising rig count in international market may have lent support to oilfield service.
Core Laboratories (CLB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
It looks like Core Laboratories N.V. (NYSE:CLB) is about to go ex-dividend in the next 3 days. You can purchase shares...
Today we are going to look at Core Laboratories N.V. (NYSE:CLB) to see whether it might be an attractive investment...
For one, it possesses the strongest economic moat across our entire oilfield services coverage. The company's foundational core analysis business in the reservoir description segment, in particular, has been virtually unchallenged over the past three decades. The downturn in oil and gas activity beginning in late 2014 has depressed financial results for most oilfield services companies, and Core Lab hasn't fully escaped the effects.